Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:44 pm Purchase | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,795,735 6.000% | 463,190 (+34.76%) | Filing History |
| 2024-08-22 6:10 pm Purchase | 2024-08-12 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,760,888 5.700% | 760,888 (+38.04%) | Filing History |
| 2024-04-25 4:48 pm Purchase | 2024-04-15 | 13G | Century Therapeutics, Inc. IPSC | Bain Capital Life Sciences Opportunities III LP | 5,320,331 6.600% | 5,320,331 (New Position) | Filing History |
| 2024-02-14 5:20 pm Purchase | 2024-02-07 | 13G | Kyverna Therapeutics, Inc. KYTX | Bain Capital Life Sciences Opportunities III LP | 3,163,868 7.400% | 3,163,868 (New Position) | Filing History |
| 2024-02-13 6:51 pm Sale | 2023-12-31 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,332,545 5.500% | -658,369 (-33.07%) | Filing History |
| 2024-02-13 6:50 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 0 0.000% | -224,669 (Position Closed) | Filing History |
| 2024-02-13 6:47 pm Unchanged | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,000,000 4.700% | 0 (Unchanged) | Filing History |
| 2023-06-01 4:45 pm Purchase | 2023-05-22 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,000,000 5.000% | 2,000,000 (New Position) | Filing History |
| 2023-02-24 4:45 pm Purchase | 2023-02-15 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,990,914 9.990% | 1,990,914 (New Position) | Filing History |
| 2022-11-18 4:16 pm Purchase | 2022-11-09 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 224,669 5.000% | 224,669 (New Position) | Filing History |